Binder profile
CHEMBL3952026
Bioactivity hit from ChEMBL on a similar protein.
Bound to: PA1498 — pyruvate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3952026- UniProt (similar protein)
Q6GG09- pchembl
- 7.960
- Target protein
- PA1498
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 411.1
- LogP ≤ 5 4.05
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 78.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(Nc1nc2cc(Br)ccc2[nH]1)c1cc(Br)ccc1OO=C(Nc1nc2cc(Br)ccc2[nH]1)c1cc(Br)ccc1O
InChI=1S/C14H9Br2N3O2/c15-7-2-4-12(20)9(5-7)13(21)19-14-17-10-3-1-8(16)6-11(10)18-14/h1-6,20H,(H2,17,18,19,21)InChI=1S/C14H9Br2N3O2/c15-7-2-4-12(20)9(5-7)13(21)19-14-17-10-3-1-8(16)6-11(10)18-14/h1-6,20H,(H2,17,18,19,21)
IABZCTFGUMVLJC-UHFFFAOYSA-NIABZCTFGUMVLJC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Curation
- pdb_similarity_tanimoto
- Binding sites
- PF02887
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3952026 →
- UniProt UniProt Q6GG09 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3952026”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1498.
PDB 10
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 68
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).